Page last updated: 2024-10-19

melatonin and Adrenocortical Carcinoma

melatonin has been researched along with Adrenocortical Carcinoma in 1 studies

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research Excerpts

ExcerptRelevanceReference
"Metformin has been proposed as a novel anti-cancer drug for adrenocortical carcinoma (ACC) based upon Poli's recent preclinical studies that 1."7.85Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study. ( Brown, RE; Buryanek, J; McGuire, MF, 2017)
"Metformin has been proposed as a novel anti-cancer drug for adrenocortical carcinoma (ACC) based upon Poli's recent preclinical studies that 1."3.85Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study. ( Brown, RE; Buryanek, J; McGuire, MF, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, RE1
Buryanek, J1
McGuire, MF1

Other Studies

1 other study available for melatonin and Adrenocortical Carcinoma

ArticleYear
Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.
    Annals of clinical and laboratory science, 2017, Volume: 47, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antioxidants; Biomarkers, Tumor; Drug The

2017